Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Hematology (Amsterdam, Netherlands)|February 18, 2004
Molecular monitoring of minimal residual disease in patients with multiple myelomaRoland Fenk, Rainer Haas, Ralf Kronenwett
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|April 22, 2011
High-dose therapy and autologous peripheral blood stem cell transplantation in patients with multiple myelomaRainer Haas, Ingmar Bruns, Guido Kobbe, et al.
Leukemia Research|April 20, 2006
Successful treatment of relapsed AML after allogeneic stem cell transplantation with azacitidineThorsten Graef, Andrea Kuendgen, Roland Fenk, et al.
Angiogenesis|January 10, 2006
Use of RNA interference to inhibit integrin subunit alphaV-mediated angiogenesisThorsten Graef, Ulrich Steidl, Wolfgang Nedbal, et al.
European Radiology|October 10, 2007
Comparison of whole-body 64-slice multidetector computed tomography and conventional radiography in staging of multiple myelomaPatric Kröpil, Roland Fenk, Lars B Fritz, et al.
Hematological Oncology|June 21, 2007
Prognostic factors for patients with acute myeloid leukaemia or high-risk myelodysplastic syndromes undergoing myeloablative or non-myeloablative allogeneic blood stem cell transplantationThorsten Graef, Matthias Vaupel, Roland Fenk, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 7, 2013
Molecular monitoring of minimal residual disease in the peripheral blood of patients with multiple myelomaMark Korthals, Nina Sehnke, Ralf Kronenwett, et al.
Leukemia Research|January 29, 2008
Unrelated umbilical cord blood transplantation as salvage treatment for engraftment failure following autologous stem cell transplantationRoland Fenk, Frank Neumann, Barbara Fenk, et al.
Experimental Hematology|September 20, 2006
Sustained G-CSF plasma levels following administration of pegfilgrastim fasten neutrophil reconstitution after high-dose chemotherapy and autologous blood stem cell transplantation in patients with multiple myelomaRoland Fenk, Nadine Hieronimus, Ulrich Steidl, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 13, 2011
The level of minimal residual disease in the bone marrow of patients with multiple myeloma before high-dose therapy and autologous blood stem cell transplantation is an independent predictive parameterMark Korthals, Nina Sehnke, Ralf Kronenwett, et al.
Pageof 9